Archive for the ‘Penny Stocks’ Category

Penny Buzz Stocks – LNG, SECI, UCHC

Friday, June 4th, 2010

Here are 3 penny stocks to add to your watch list today:

Cheniere Energy, Inc. (AMEX:LNG): Shares up after the company announced plans to export U.S. natural gas overseas from its Sabine Pass terminal in Louisiana in a strategy shift prompted by large increases in U.S. natural gas production.

Sector 10, Inc. (OTCBB: SECI): Up 30 percent on high volume after the company announced the upcoming release of the PLX-3D integration software package and its integrated components as an easy to use mobile application for the iPhone and iPad produced by Apple.

Uni Core Holdings Corp. (OTCBB: UCHC): Up 32 percent today on decent volume. Recent developments include a new research report from Skymark Research, and plans to close the acquisition of APT Paper Group, which includes FG Management Company Limited, Global Golden Group Investments Co., Ltd., Wise Link Management Ltd., Plan Star Development Limited, and Sure Strong Limited. Uni Core Holdings Corp. is an ‘incubator’ of mid- to large-size companies in China.

M&A activity for small and mid-cap biotechs could pick up in 2010, JP Morgan analyst says

Wednesday, June 2nd, 2010

Earlier this year, J.P. Morgan’s senior biotech analyst, Geoff Meacham gave his macro view of the biotech industry. “M&A activity for small and mid-cap biotech may pick up, driven by Pharma but also driven by large cap biotechs,” he said. “In this report, we’ve stressed pipelines and sustainability of growth, but as growth in the large cap group matures, increased cash flow generation may fuel increased M&A activity.”

A few notable names with “high strategic values” included: Acorda Therapeutics, Inc. (Nasdaq: ACOR), AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG), OSI Pharmaceuticals, Inc. (Nasdaq: OSIP), Medivation, Inc. (Nasdaq: MDVN), United Therapeutics Corp. (Nasdaq: UTHR), Vertex Pharmaceuticals, Inc. (Nasdaq: VRTX), Human Genome Sciences, Inc. (Nasdaq: HGSI), Seattle Genetics, Inc. (Nasdaq: SGEN) and Savient Pharmaceuticals, Inc. (Nasdaq: SVNT).”

Lehman bullish on small, mid-caps, too:

“Opportunities for the U.S. biotechnology group are selective and we tend to prefer small-mid cap stocks over large-cap stocks overall in 1H10,” said Lehman Brothers analyst, Jim Birchenough. “Within the large cap group our rank order of preference is Amgen, Genzyme and Celgene as top picks with Gilead and Biogen Idec viewed less favorably. Top mid-cap picks include Amylin Pharmaceuticals (Nasdaq: AMLN), Cephalon (Nasdaq: CEPH), Human Genome Sciences (Nasdaq: HGSI), Onyx Pharmaceuticals (Nasdaq: ONXX) and Regeneron Pharmaceuticals(Nasdaq: REGN) while we are less positive on Theravance (Nasdaq: THRX), OSI Pharmaceuticals (Nasdaq: OSIP) and Zymogenetics(Nasdaq: ZGEN).

Biotech Buzz Stocks for 2010:

Here are a few of our favorite small and mid cap biotech Buzz Stocks for 2010:  Akorn, Inc. (Nasdaq: AKRX), Neurocrine Biosciences, Inc. (Nasdaq: NBIX), Metabolix, Inc. (Nasdaq: MBLX), and Raptor Pharmaceuticals Corp.

Let us know your top biotech picks!

Penny Buzz Stocks to Watch – ENMD, IMUC, OOAG

Wednesday, June 2nd, 2010

Here are a few penny stocks on our radar today and why:

Entremed, Inc. (Nasdaq: ENMD): announced the publication of preclinical results for its clinical-stage Aurora A/angiogenic kinase inhibitor, ENMD-2076, in human colorectal cancer xenograft models. ENMD-2076 demonstrated robust antitumor activity against murine xenograft models of human colorectal cancer (CRC) established from both cell lines and primary human samples.

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC): Announced positive results from a Phase I study of the company’s immune-based cancer therapy, ICT-107.

OMDA Oil and Gas, Inc. (Pink Sheets: OOAG): Announced a reduction of 12,000,000 common shares which is 5 percent of the total outstanding share count. Upon the completion of all of the announced share retirements the new outstanding share count will stand at 172,610,100. In total OMDA Oil and Gas, Inc. will have reduced its outstanding share total nearly 30% from the original 242,610,100. Upon completion of all pending share cancellations OMDA’s insiders will collectively hold less than 10% of the common vote.

Sign up for our Buzz Stock alerts via e-mail and get our Buzz Stocks first!

Vasomedical, Inc. (VASO) – Penny Stock of the Day

Monday, May 24th, 2010

Shares of Vasomedical, Inc. (OTCBB: VASO) were up as much as 86 percent on Monday after the company announced that its subsidiary was appointed the exclusive representative for select GE Healthcare Diagnostic Imaging products to specific market segments in the 48 contiguous states of the United States and District of Columbia received signed a sales representative agreement. GE Healthcare is the healthcare business unit of GE (NYSE: GE – News). The Company has already received financial commitments for up to $5 million to fund this project.

[–quote–]

“This representation agreement is an example of Vasomedical’s strategy to expand its operations into new areas of potential growth in healthcare,” stated Abraham E. Cohen, Chairman of the Board of Vasomedical, Inc. in a statement.

The agreement is for an initial term of three years commencing July 1, 2010, subject to extension and also subject to earlier termination under certain circumstances.

Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting EECP(R) external counterpulsation systems based on the Company’s proprietary technology. Offered exclusively by Vasomedical, EECP therapy is a safe, non-invasive, outpatient treatment option for patients suffering from ischemic heart diseases such as angina and heart failure

In early April, the company announced that it received clearance from the U.S. Food and Drug Administration to market its Vasomedical-BIOX™ Model 2301 Combined ECG Holter and Ambulatory Blood Pressure Monitoring Recorder and Software Analysis System.

“These are the first in a line of Vasomedical-BIOX™ ECG Holter and Ambulatory Blood Pressure Monitoring Systems that Vasomedical intends to bring to the marketplace,” said Dr. Jun Ma, President and CEO of Vasomedical, Inc.

Shares of Vasomedical are up more than 300 percent over the past 12 months.

What are penny stocks?

Saturday, June 20th, 2009

In U.S. financial markets, penny stocks commonly refer to any stock trading outside one of the major exchanges (NYSE, Nasdaq, or AMEX), and is often considered very risky.

In the UK, penny shares as they are more commonly called, usually refer to a stock and shares in small cap companies, which is defined as being companies with a market capitalization of less than £100 million and/or a share price of less than £1 with a bid/offer spread greater than 10 percent. In the UK Penny Shares are covered by a standard regulatory risk warning issued by the Financial Services Authority(FSA).

Trading penny stocks is the easiest way to make the large profits with the least amount of startup capital. Why? Because of their volatility. It’s a lot more difficult to find a $50 stock that goes up 100 percent in a short time, but there are hundreds of penny stocks that go from a penny to two cents, a dime to 20 cents, or a dollar to two dollars in a matter of days.

There are risks associated with trading penny stocks. In many cases these risks can be mitigated or avoided altogether, but there is always the chance of losing money.

Penny stocks have a bad name, because scammers use thinly traded shares to take advantage of people, with pump and dump schemes, and by providing manipulative information. Penny stocks also get a bad name because many investors lose money trading them, when they don’t understand what their investing in, or how to trade these penny stocks. Many people trade penny stocks before they learn about the easily avoidable dangers, and then complain that penny stocks are dangerous. However, for those investors who do learn how to find good quality companies, and take the time to understand the dangers and how to avoid them, there are tremendous profits to be made.

During a ten year period between 1993 and 2003, the growth in the volume of shares traded on the OTCBB — almost entirely comprised of penny stocks — eclipsed trading volume on the Nasdaq and NYSE (See Figure 1).

Figure 1: Volumes for the Nasdaq and OTCBB. OTCBB volume grew 8900 percent between 1993 and 2003, eclipsing both the Nasdaq (638 percent) and NYSE (512 percent) volume increases by a wide margin.

Volumes on the Pink Sheets  have grown even faster. In 1998, about 9 billion shares traded, and by 2003, volumes had surged to 187.5 billion–an incredible increase of more than 2000% in just five years. (See Figure 2).

Figure 2: Rise in trading volumes on the Pink Sheets

How do you trade penny stocks? Are there any techniques that work best?

Technical analysis that uses indicators and statistics to predict price movements is one possible approach, according to Investopedia. But due to the rampant growth of the penny stock phenomenon, technicians haven’t had the time to build a strategy–assuming anyone is interested in coming up with one. As far as analyzing sub-penny stocks, it would require a new system for charting and monitoring to determine the significance of a 0.0001-cent move, and there is no telling whether or not it would work.